Clinical features of myelokathexis and treatment with hematopoietic cytokines: a case report of two patients and review of the literature

J Pediatr Hematol Oncol. 1997 Sep-Oct;19(5):443-8. doi: 10.1097/00043426-199709000-00007.

Abstract

Purpose: To define the features and course of myelokathexis, a rare congenital neutropenia resulting from impaired release of granulocytes from bone marrow.

Methods: The clinical features, granulocyte function, lymphocyte function, and response to granulocyte colony-stimulating factor (G-CSF) of two patients (mother/son) with myelokathexis were studied. This experience and 14 previous reports lead to a composite description of myelokathexis.

Results: Both patients had chronic neutropenia, recurrent pulmonary infections, bone marrow consistent with myelokathexis, hypogammaglobulinemia, and elevated endogenous G-CSF. Patient 15 had normal granulocyte function, a rise in absolute neutrophil count (ANC) with epinephrine and hydrocortisone, and normal numbers of T- and B-lymphocytes; she also had numerous warts during childhood. Both patients experienced a transient increase in ANC with infection, a significant increase in ANC within 5 hours following a single dose of G-CSF, and fewer infections with daily G-CSF.

Conclusions: Based on 16 cases, myelokathexis occurs more often in females and frequently affects multiple members of a family. The usual number of circulating granulocytes is low although function is normal. Mature marrow granulocytes are mobilized with infection, corticosteroids, epinephrine, G-CSF, and granulocyte-macrophage colony-stimulating factor (GM-CSF). Lymphocyte number is normal but lymphocyte function is abnormal as evidenced by hypogammaglobulinemia and papillomavirus infection.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adult
  • Bone Marrow / pathology*
  • Epinephrine / therapeutic use
  • Female
  • Granulocyte Colony-Stimulating Factor / blood
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Granulocytes / pathology
  • Granulocytes / physiology
  • Humans
  • Hydrocortisone / therapeutic use
  • Infant
  • Leukocyte Count
  • Male
  • Neutropenia / genetics
  • Neutropenia / pathology
  • Neutropenia / therapy*

Substances

  • Granulocyte Colony-Stimulating Factor
  • Hydrocortisone
  • Epinephrine